CM512 injection

BIOLOGICAL2 trials

Sponsors

Keymed Biosciences Co.Ltd

Conditions

AsthmaChronic Spontaneous Urticaria (CSU)

Phase 2

Study of CM512 Injection in Subjects With Moderate-to-severe Asthma

RecruitingNCT07011524

Keymed Biosciences Co.LtdAsthma

Start: 2025-08-19End: 2027-07-21Target: 200Updated: 2025-08-28

Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)

RecruitingNCT07166211

Keymed Biosciences Co.LtdChronic Spontaneous Urticaria (CSU)

Start: 2025-11-27End: 2027-01-14Target: 48Updated: 2026-04-09